Fig. 5From: Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndromeOveral survival of MDS patients with MF-2/3 classified by treatment (transplant VS. non-transplant)Back to article page